Latest Articles
'13 years of fighting for answers': Bindi Irwin gives health update after undergoing emergency surgery in the US - 9Honey Celebrity
'13 years of fighting for answers': Bindi Irwin gives health update after undergoing emergency surgery in the US 9Honey Celebrity
Published: Aug. 13, 2025, 9:36 p.m.
GnRH Antagonists Market on Upward Trajectory During the Forecast Period (2025-2034) Across the 7MM | DelveInsight - PR Newswire UK
GnRH Antagonists Market on Upward Trajectory During the Forecast Period (2025-2034) Across the 7MM | DelveInsight PR Newswire UK
Published: Aug. 13, 2025, 9:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights The Manila Times
Published: Aug. 13, 2025, 8:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire
Published: Aug. 13, 2025, 8:17 p.m.
Acrivon's Cancer Drug Pipeline Advances with Tumor Response in Endometrial Cancer Trials - Stock Titan
Acrivon's Cancer Drug Pipeline Advances with Tumor Response in Endometrial Cancer Trials Stock Titan
Published: Aug. 13, 2025, 8:15 p.m.
GnRH Receptor Antagonists Market Poised for Significant - openPR.com
GnRH Receptor Antagonists Market Poised for Significant openPR.com
Published: Aug. 13, 2025, 7:52 p.m.
Le Wand just made luxury vibrators more affordable than ever - Mashable
Le Wand just made luxury vibrators more affordable than ever Mashable
Published: Aug. 13, 2025, 4:57 p.m.
Unavoidable forever chemicals may be associated with severe endometriosis - Medical Xpress
Unavoidable forever chemicals may be associated with severe endometriosis Medical Xpress
Published: Aug. 13, 2025, 2:46 p.m.
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis - Nature
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis Nature
Published: Aug. 13, 2025, 2:22 p.m.
Q&A: Endometrial Cancer - Medscape
Q&A: Endometrial Cancer Medscape
Published: Aug. 13, 2025, 2:13 p.m.
Link copied to clipboard!